The Top 50 Healthcare Technology CEOs of 2022

David Beckam

The Healthcare Technology Report is pleased to announce the Top 50 Healthcare Technology CEOs of 2022. This year’s list comprises a wide array of some of the most accomplished executives in the healthcare technology industry. They have led their firms in advancing and revolutionizing healthcare solutions, spearheading innovations in patient experience and software platforms, medical devices, therapeutics, and other areas.

When the COVID-19 pandemic began, Mick Farrell led ResMed’s global pivot to a 350% increase in production volume of lifesaving ventilators and breathing circuits that helped save hundreds of thousands of lives worldwide. Mike Mussallem has not only led the development and successful implementation of Edwards Lifesciences’ patient-focused innovation strategy, but also established Edwards’ commitment to philanthropy and corporate social responsibility. And as Chairman of Access Healthcare, Anurag Jain has helped his firm scale from 100 people in 2012 to over 18,000 global employees today, while also devoting time to philanthropy and his venture capital firm.

This year’s awardees have also impacted the broader global community through their efforts beyond their organizations. Many are professors, or board members of associations and other companies advancing the healthtech field, or generous philanthropists. And in addition to overseeing their companies’ operations, nearly half either founded or co-founded the company they lead. They come from a variety of backgrounds and have wide-ranging professional histories, but they share at least one thing in common: they have all led their company to new heights through their dedication, ingenuity, and commitment to both their employees and their customers. Please join us in honoring The Top 50 Healthcare Technology CEOs of 2022.


1. Mick Farrell
Company: ResMed
Title: Chief Executive Officer

Mick Farrell is Chief Executive Officer of ResMed, a global leader in digital health, leading its mission to create and scale innovative, global, cloud-connected solutions that treat and keep people out of the hospital – particularly those living with sleep apnea, COPD, asthma, and other key chronic diseases. ResMed helped over 133 million patients in the last 12 months sleep better, breathe better, and live higher-quality lives well away from the hospital.

When the COVID-19 pandemic began, Mick led ResMed’s global pivot to 350%+ of prior production volumes of lifesaving ventilators and breathing circuits – traditionally just a small percentage of the company’s business – to help deliver the gift of breath to many hundreds of thousands of people worldwide. Before joining ResMed, he worked in management consulting, biotechnology, chemicals, and metals manufacturing at companies including Arthur D. Little, Sanofi Genzyme, Dow Chemical, and BHP.

Mick serves on the board of directors of ResMed (NYSE: RMD), the Advanced Medical Technology Association (AdvaMed), and Zimmer Biomet (NYSE: ZBH). He also volunteers as a trustee for non-profit organizations: UC San Diego Foundation, Rady Children’s Hospital, and Father Joe’s Villages’ project for the homeless in San Diego, California. He holds a Bachelor of Engineering from the University of New South Wales, a Master of Science in Chemical Engineering from the Massachusetts Institute of Technology, and a Master of Business Administration from the MIT Sloan School of Management.


2. Mike Mussallem
Company: Edwards Lifesciences
Title: Chair and Chief Executive Officer

Mike Mussallem has served as Chair and Chief Executive Officer of Edwards Lifesciences since 2000, when it became an independent, publicly traded company. Under his leadership, Edwards has established itself as a global leader in patient-focused medical innovations with the introduction of lifesaving and life-sustaining therapies such as transcatheter aortic valve replacement, new resilient surgical valves designed for active patients, and non-invasive hemodynamic monitoring. During his tenure, he has not only led the development and successful implementation of the company’s patient-focused innovation strategy, but also established Edwards’ commitment to philanthropy and corporate social responsibility.

Edwards Lifesciences, along with the Edwards Lifesciences Foundation and its Every Heartbeat Matters initiative, has donated more than $130 million to support underserved patients globally and communities where Edwards’ employees live and work. Under Mussallem’s leadership, Edwards has been recognized with multiple awards and honors by various organizations including Dow Jones Sustainability Indices, Ethisphere Institute, Forbes, JUST Capital, Newsweek, and the Wall Street Journal. Additionally, Mussallem has received several honors, including being named one of the Top 50 Healthcare Technology CEOs by The Healthcare Technology Report and the Harvard Business Review in its annual Best-Performing CEOs in the World list.

Previously, Mussallem held a variety of positions at Baxter International between 1979 and 2000. In addition to his current role at Edwards, Mussallem serves on the board of AdvaMed and is an advisory board member for the Leonard D. Schaeffer Center for Health Policy & Economics. He is a trustee of the University of California, Irvine Foundation and the Rose-Hulman Institute of Technology in Terre Haute, Indiana, where he received his Bachelor’s in Chemical Engineering and an honorary doctorate. Mussallem has served as Board Chairman of both AdvaMed and the California Healthcare Institute.


3. Geoff Martha
Company: Medtronic
Title: Chairman and Chief Executive Officer

Geoff Martha is Chairman and Chief Executive Officer of Medtronic, leading the $30 billion company and its 90,000 employees in pursuit of fulfilling its Mission to use technology to improve human welfare. FORTUNE Magazine named Medtronic to its 2020 “Change the World” list, recognizing its swift efforts during the pandemic, and included Medtronic as a “Most Admired” company in 2021 and 2022. Martha is recognized as a driven and innovative leader, ranking as an influential executive by publications like Modern Healthcare and the Healthcare Technology Report. He joined Medtronic in 2011 and led the acquisition and integration of Covidien, the largest acquisition in the history of medtech.

Before joining Medtronic, he spent 19 years at GE Healthcare and GE Capital. An ardent supporter of philanthropic and diversity initiatives, he serves on the Board of Trustees for the Asia Society and is a member of the Board of Directors for the Medtronic Foundation, Children’s HeartLink, and the Northside Achievement Zone. He is also part of OneTen, a coalition of cross-industry leaders committed to breaking down systemic barriers for Black Americans, and serves as Medtronic’s Executive Sponsor to FIRST Robotics. He earned a Bachelor’s in Finance from Penn State University.


4. Anurag Jain
Company: Access Healthcare
Title: Chairman and Chief Executive Officer

Anurag Jain is a futurist, entrepreneur, philanthropist, and venture capitalist focused on charting a better course for humanity by pioneering solutions to the world’s most complex problems. He is currently the Chairman of Access Healthcare, a healthcare services platform utilizing AI and RPA to transform the revenue cycle management industry, and has seen it scale from 100 people in 2012 to over 18,000 global employees today.

He also co-founded Brigade Corporation, an international customer support company. He was an early pioneer in the Indian IT and Business Process Outsourcing industry as a founder of Vision Healthsource. He subsequently went on to lead the 41,000-strong global workforce of Dell Services (formerly Perot Systems).

As the Managing Partner of Perot Jain, LP, a Dallas-based venture capital firm, he has invested heavily in various exponential technologies to help build 50 highly disruptive, industry-transforming companies. He currently serves on the Board of Directors of the US India Chamber of Commerce, and as Chairman-Emeritus of the North Texas Food Bank (NTFB). He was awarded the BITS Distinguished Alumnus Award in Public Life/Entrepreneurship/Philanthropy in recognition of his outstanding contributions to society and as an entrepreneurial leader. He was also the recipient of the EY Entrepreneur of the Year award in 2016. He received his Master in Business Administration from the University of Michigan and a Bachelor of Engineering with honors in Electrical and Electronics Engineering from the Birla Institute of Technology and Sciences in Pilani, India.


5. David Sides
Company: NextGen Healthcare
Title: President and Chief Executive Officer

David Sides is President and Chief Executive Officer of NextGen Healthcare, a leading provider of cloud-based, ambulatory-focused technology solutions. Sides joined the company in September 2021, bringing a breadth of global commercial and operations experience leading premier healthcare technology companies. Raised in a family of physicians, he is motivated to alleviate physician burnout and improve the patient-provider connection. He is a passionate champion of the company’s vision of “Better healthcare outcomes for all.”

Shortly after joining NextGen Healthcare, Sides initiated the development of a 5-year strategic plan, while also keeping a sharp focus on speed of execution. Under his leadership, NextGen Enterprise became the first complete EHR to earn ONC Health IT Cures Update certification. Its enterprise practice management (11-75 providers) and small practice EHR (1-10 providers) solutions were ranked Best in KLAS. And the company was named one of America’s Most Trusted Companies 2022 by Newsweek as well as a Forbes 2022 Best Midsize Employer.

Sides brings a spirit of innovation and teamwork to NextGen Healthcare. His extensive leadership experience includes Chief Operating Officer at Teladoc Health, CEO of Streamline Health, board member of EMIS Group, and 17 years at Cerner Corporation. He holds a Bachelor’s in Biophysics from the University of California, Berkeley, and a Master of Business Administration and Master of Health Administration from the University of Missouri, Columbia.


6. Chris Smith
Company: Ortho Clinical Diagnostics
Title: Chairman and Chief Executive Officer

With over 30 years of healthcare sector experience and a proven track record driving value creation for multinational businesses, Chris Smith, Chairman and Chief Executive Officer of Ortho Clinical Diagnostics, has already made incredible strides for the company during his less-than-two-year tenure at the former J&J spinoff. Not only was he charged with leading one of the world’s largest pure-play in vitro diagnostics (IVD) companies during the global COVID-19 pandemic, but he was also instrumental in taking the previously private equity-owned company public in January 2021. Upon Smith’s arrival in late 2019, he encouraged the team to look at the company’s product offerings and reinvest R&D dollars into strengthening the company’s offerings and building out its pipeline. This investment has paid off, as Ortho launched more than 75 new or improved assays in the past few years.

Prior to joining Ortho, Smith served as the CEO of Cochlear Limited, a publicly-traded global medical device company headquartered in Australia. Under his leadership, Cochlear Limited reached annual sales in excess of AU $1 billion while the market cap of the company more than doubled. Prior to Cochlear, he held several senior executive roles, including CEO in Residence for Warburg Pincus and Global Group President of Gyrus Group Plc., a surgical products company. He serves on the boards of directors of several companies, including Results Physiotherapy, Nyxoah, and Akouos, and was a Senior External Advisor for McKinsey & Co., AngelMD, and EQT Partners. He previously served on the boards of directors of publicly-listed Xtent Inc. as well as Startek Inc., Universal Biosensors, Gyrus Group Plc, and Acclarent Inc. He holds a Bachelor of Science from Texas A&M University.


7. Dan Rodrigues
Company: Tebra
Title: Co-founder, Chairman of the Board, and Chief Executive Officer

Dan Rodrigues is a Co-founder, Chairman of the Board of Directors, and Chief Executive Officer of Tebra, the leader in practice growth technology and cloud-based clinical and financial software. Tebra formed with the merger of Kareo and PatientPop in 2021. Today, it helps over 100,000 healthcare providers run more efficient and profitable practices while delivering outstanding patient care. Headquartered in Southern California, Tebra has over 1,000 employees who are passionate about improving healthcare.

Rodrigues founded Kareo in 2004 with the vision of making medical billing easy for doctors and their staff. Prior to launching Kareo, he started creating technology for the healthcare industry in 2001 as a Co-founder and Managing Partner of Skematix, a software consulting firm based in Southern California. In the late 1990s, he was the Co-founder and CEO of Scour, a very popular search engine for finding music and video files online used by more than 10 million consumers. He began his career as a software developer for RealNetworks and Visio and holds a Bachelor of Science in Computer Science from the University of California, Los Angeles.


8. Mike Gordon
Company: ArisGlobal
Title: Chief Executive Officer

Mike Gordon is the Chief Executive Officer of ArisGlobal, which is transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market. Its end-to-end drug development technology platform, LifeSphere®, integrates its proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle.

With more than 18 years of experience, Gordon has held several senior-level global leadership roles of increasing scope and responsibility, mainly within technology-focused organizations. His most recent corporate leadership role was with Callcredit Information Group as CEO, where he oversaw a successful transformation of the business and an eventual sale to Transunion. He also currently serves on the board of directors of three technology companies: Fintech, Hometrack, and Constructionline.

Prior to Callcredit Information, he served as FICO’s Executive Vice President of Sales, Services, and Marketing, after serving in various roles of increasing responsibility across the company’s banking, insurance, retail, healthcare, and pharmaceutical markets. Before joining FICO in 2005, he spent more than 13 years in the financial services industry. As a Vice President at Capgemini, his competency was in providing strategic and operational solutions to banking and insurance providers, leading the Insurance Center of Excellence and Solutions. He received a Master of Business Administration in Finance and Business Economics from The University of Chicago Graduate School of Business and a Bachelor of Science in Industrial Engineering/Operations Research from Northwestern University.


9. Annette Brüls
Company: Medela
Title: Chief Executive Officer

Annette Brüls serves as Chief Executive Officer of Medela. Headquartered in Switzerland, Medela is dedicated to developing innovations that build better outcomes and nurture health for generations, providing leading research-based breast milk feeding and baby products, healthcare solutions for hospitals, and clinical education. Under Brüls’ leadership, Medela has accelerated its innovation pipeline, with newly launched products now accounting for more than 50% of Medela’s sales.

Brüls has held a number of global leadership positions in several multinational companies, most recently as President of Diabetes Service & Solutions at Medtronic. Since joining Medela in 2018, she has nurtured a global culture that focuses on people, passion, and purpose, lifting the employee net promote score (eNPS) by 30 points in three years. Actively helping moms return to work, she encouraged the creation of part-time jobs. Under her leadership, Medela became a member of the UN Global Compact, cementing the company’s ESG commitment within its corporate strategy. Based on employee feedback, she was awarded Best CEO in 2020 and 2021 by Comparably and was covered by CNBC and Business Insider. A Belgium native, Brüls holds a Bachelor and Master of Science in Electrical Engineering from the University of Liège. She currently serves on the board of Coloplast.


10. T. Scott Law
Company: Zotec Partners
Title: Founder and Chief Executive Officer

T. Scott Law is the Founder and Chief Executive Officer of Zotec Partners, a healthcare solutions company enhancing the financial experience for providers and patients. He founded the Company in 1998 as he witnessed healthcare starving for technology. His unique experience as a CPA and leader within the insurance industry has helped him grow Zotec into the country’s largest privately-held provider of revenue cycle and practice management solutions. Under Law’s leadership, Zotec has created long-standing partnerships with providers of all sizes and specialties, including facilitating millions of COVID-19 vaccines and tests with its patient engagement platform. The company is on a mission to make a difference by simplifying the financial experience of healthcare.

Previously, Law served as CFO/CIO of a medical billing company subsidiary of Anthem. Like healthcare, he’s committed to the community and serves as Chairman of Zotec Partners Foundation, supporting charities to make brighter futures for at-risk youth. He is pleased to partner with impactful nonprofits like First Tee, Nicklaus Children’s Health Care Foundation, Folds of Honor, and many more. Scott received a Bachelor’s in Accounting from Butler University, where he still volunteers his time as an advisor for the business school.


11. Scott MacKenzie
Company: RevSpring
Title: Chief Executive Officer

Scott MacKenzie is the Chief Executive Officer for the Nashville-headquartered RevSpring. He is a veteran of healthcare industry technology, with over 25 years of leadership experience in consumer engagement, analytics, payments, and digital transformation. Since joining the company in March of 2019, he has been the driving force in advancing patient engagement and payment solutions that inspire patients to participate in and pay for their healthcare. With his unique approach, combining innovation, data, and empathy, he has led RevSpring to reimagine the patient experience. Under his leadership, RevSpring has introduced and advanced several new products that addressed their customers’ patient engagement and payment collection goals.

Previously, MacKenzie served as CEO of M*Modal, a leading technology provider of advanced clinical documentation solutions. M*Modal focused on increasing productivity and the user experience of healthcare providers by seamlessly integrating technology and services to improve clinical documentation, allowing physicians to focus on their patients and providing care.

Prior to that, he was CEO of Passport Health Communications, where he served as President of Experian Health. Scott was also part of McKesson Corporation as President of RelayHealth Pharmacy Solutions. He also held executive positions at Cerner Corporation, running its Providing Care business unit.

MacKenzie holds a Master of Business Administration from the University of Michigan and a Bachelor of Science from Utah State University.


12. Dr. Adam de la Zerda
Company: Visby Medical
Title: Founder and Chief Executive Officer

Dr. Adam de la Zerda is the Founder and Chief Executive Officer of Visby Medical, a diagnostics company that is transforming the order of diagnosis and treatment for infectious diseases. The Visby Medical platform is the first instrument-free, single-use PCR device that fits in the palm of your hand and rapidly tests for serious infections. Visby Medical has been awarded funding from several agencies, including the Biomedical Advanced Research and Development Authority (BARDA), the National Institutes of Health (NIH), and the Rapid Acceleration of Diagnostics (RADx), to develop their platform.

Dr. de la Zerda is an Associate Professor at Stanford University School of Medicine. In 2012, he became the youngest tenure track faculty at Stanford Medical School. He has received over 20 honors and awards, including Forbes Magazine 30-under-30 in Science and Healthcare in 2013 and 2014, a Chan-Zuckerberg Biohub investigatorship, and the DP5 Early Independence Award from the Director of the NIH. Dr. de la Zerda received his Bachelor of Science in Computer Science, Electrical Engineering, and Physics from the Technion – Israel Institute of Technology, as well as his Doctor of Philosophy in Electrical Engineering from Stanford University.


13. Daniel Cane
Company: ModMed
Title: Co-founder and Chief Executive Officer

Daniel Cane is Co-founder and Chief Executive Officer of South Florida-based ModMed, a software company with a mission to place doctors and patients at the center of care through an intelligent, specialty-specific cloud platform. Founded in 2010, ModMed is frequently recognized both nationally and regionally for its achievements under Cane’s leadership. Today, it powers thousands of ambulatory surgical and medical specialty practices and ASCs across the country, improving efficiency for millions of provider and patient interactions. In 2020, the company was named one of the Best Workplaces to Work by Inc. magazine. The South Florida Business Journal also selected ModMed as the Business of the Year in 2012, 2015, 2018, and 2022.

Before ModMed, Cane co-founded Blackboard Inc. as an undergraduate and raised over $100 million in venture capital. In 2004, he helped take the company public on the NASDAQ (BBBB). He is active in his community and serves on the boards of trustees of Florida Atlantic University, the South Florida Science Center and Aquarium, and the Boca Raton Chamber of Commerce. In 2018, he helped to establish the Cane Institute for Advanced Technologies at Henderson/FAU High School. Cane received his Bachelor of Science in Applied Economics from Cornell University.


14. Brent Lang (tie)
Company: Vocera Communications, Inc.
Title: Chairman and Chief Executive Officer

Chairman and Chief Executive Officer Brent Lang has transformed Vocera Communications into a force for innovation in global healthcare markets. Lang first joined Vocera when it was only a startup nearly two decades ago, passing through the ranks of Vice President and Chief Operating Officer before taking up his current role in 2013. Under Lang’s stewardship, Vocera has grown into a titan in the worlds of clinical communications and workflow solutions, generating revenues of roughly $200 million last year and a market capitalization representing more than $1.2 billion.

Apart from his nearly two decades of steering Vocera to new heights in various leadership positions, Lang also worked as a Senior Director at computer networking firm 3Com. In addition to numerous professional publications and honors from academic and entrepreneurship entities, he is an active volunteer, serving on the leadership council of the Positive Coaching Alliance and as Independent Director for U.S.A. Gymnastics. He received his Bachelor of Science in Industrial and Operations Engineering from the University of Michigan and his Master of Business Administration from the Stanford University Graduate School of Business. Lang was a member of the 1988 U.S. Olympic Swimming Team and won a Gold Medal in the 4X100 Freestyle Relay at the Summer Olympics in Seoul, South Korea.


14. Scott Shreeve (tie)
Company: Crossover Health
Title: Founder and Chief Executive Officer

Scott Shreeve, MD, is the Founder and Chief Executive Officer of Crossover Health. Under his leadership, Crossover has become a nationally recognized leader in delivering value-based hybrid care to employers nationwide, including such notable names as Apple, Comcast NBCUniversal, Meta, and Microsoft. As an emergency medicine physician, Dr. Shreeve created Crossover to deliver Health As It Should Be. Rooted in Crossover’s Advanced Primary Health model, he has built an organization that creates industry-leading member satisfaction and provider retention rates.

Prior to starting Crossover, Dr. Shreeve co-founded Medsphere Systems Corporation, the first open-source electronic health record for the healthcare enterprise, which drove the fulfillment of large-scale electronic health record implementations for community hospitals, statewide health systems, and primary care clinic networks. He is also a founding member of the Health 2.0 technology and reform movement, serving as an advisor to the conference and a national spokesperson. Dr. Shreeve earned his Bachelor of Science from Brigham Young University, is a graduate of the University of Utah School of Medicine, and completed his Emergency Medicine residency training at the University of Arizona Health Science Center.


15. Johannes Roggendorf
Company: MEDWING
Title: Founder and Managing Director

Johannes Roggendorf is the Founder and Managing Director of MEDWING, a Berlin-based health tech company that aims to reduce the global shortage of healthcare professionals by providing them with the best jobs and development opportunities. Founded in 2017, MEDWING now has the largest employee pool for healthcare staff in Europe with over 400,000 professionals. Over 3,000 healthcare facilities work with MEDWING. Every month, the company records around 15,000 new registrations, over 200 professionals are placed in permanent positions, and more than 50,000 shifts are booked through the platform. It has over 300 employees and is also active in the U.K., France, and Austria. Business Insider put MEDWING on its watchlist of the 20 most promising companies in 2020, and LinkedIn voted the company the top startup in Germany in 2019.

Before MEDWING, Roggendorf founded and managed HeavenHR, which provides an all-in-one software for HR management. From 2013 to 2015, he worked as Senior Associate Consultant for Bain & Company. Previously, he was Director of Operations at Home24 AG. He received his Bachelor’s in Finance and Marketing from the University of Münster and his Master’s in Management from the ESCP Business School.


16. Florian Otto
Company: Cedar
Title: Co-founder and Chief Executive Officer

An accomplished entrepreneur and former physician, Florian Otto now drives growth and sets overall direction across all facets of Cedar’s operations. Compelled by a personal bad experience with healthcare billing, combined with a background in both the clinical and business sides of healthcare, Otto founded Cedar in 2016 with his Co-founder, Arel Lidow, to address the poor financial experience commonly seen in healthcare and improve this experience for patients.

Prior to founding Cedar, Otto was an executive at Zocdoc and also founded a daily deal company in Brazil (ClubeUrbano) that was eventually acquired by Groupon. After the acquisition, he became CEO of Groupon Brazil, growing the company to one of Groupon’s top three international markets. He began his business career as a Strategy Consultant at McKinsey & Company within their healthcare practice. He holds Doctor of Medicine, Doctor of Dental Surgery, and Doctor of Philosophy degrees from the University of Freiburg, Germany.


17. April Koh
Company: Spring Health
Title: Co-founder and Chief Executive Officer

April Koh is a Co-founder and the Chief Executive Officer of Spring Health, which is helping employers modernize their behavioral health benefits with the most effective, comprehensive solutions for employee mental wellbeing. Spring Health uses a proprietary assessment and machine-learning technology to understand all of the conditions a person may be experiencing, and then uses those results to match them to a care plan personalized to their needs. Each member has access to a Care Navigator to help guide them through their options, assist in booking appointments with therapists, and connect them to domain experts across work-life, legal, or financial services.

Koh knows that hopelessness is an all too common part of the mental health journey. She’d watched loved ones try one thing after another — some provider, some medication, some program. And every time something didn’t work, it got harder and harder to muster up the courage and the hope to start all over again. Koh predicts that in five to ten years, mental healthcare is going to look radically different: instead of being a guessing game of trial-and-error, it will be precisely and accurately tailored to each individual through data. She started Spring Health because she wanted to build that future — where the hopelessness of guessing is replaced with the hope of data-driven, accurate care.

Together with fellow Yale alum Adam Checkroud, Koh founded Spring Health in 2016. By 2022, at the age of 29, she officially became the youngest female CEO of a multibillion-dollar startup, as their company had reached a valuation of $2 billion. Koh earned a Bachelor of Arts in Sociology and Computer Science from Yale University and was a Yale Entrepreneurial Institute Summer Fellow.


18. Charlie Alvarez
Company: Stratus
Title: Chief Executive Officer

Charlie Alvarez is the Chief Executive Officer of Stratus, the nation’s leading provider of EEG services and solutions. Alvarez joined the company in 2020, right at the start of the COVID-19 pandemic and as sweeping changes were made to the CPT codes and reimbursement for EEG testing. Since joining Stratus, Alvarez has lead record-breaking growth and expanded its services to over 200 hospital systems nationwide. Additionally, the company’s proprietary software, Stratus Software Solutions, is now the market leader in cloud-based, ambulatory review software.

Prior to joining Stratus, Alvarez was CEO of Foxconn’s DCI Health Technology, Inc., and was responsible for launching the company in the United States. He joined DCI in 2017, when his previous company, Sotera Wireless Inc., was acquired by Foxconn. He had joined Sotera Wireless in 2014 as Senior Vice President of Sales and Marketing, where he was responsible for growing sales and revenue. Prior to Sotera, he was President and Co-founder of Watermark Medical, a privately held sleep diagnostics and therapy company. Alvarez has held senior leadership positions at CardioNet (Biotel/ Philips) and PSS/World Medical, now McKesson. He holds a Bachelor’s degree from Florida State University.


19. Todd Powell
Company: RefleXion Medical
Title: President and Chief Executive Officer

In 2017, Todd Powell joined RefleXion, a therapeutic oncology company using the biology of individual cancer cells to guide radiotherapy for all stages of cancer, as President and Chief Executive Officer. Designated a Breakthrough Device by the FDA for treating lung cancer in 2021, RefleXion’s disruptive technology focuses on bringing a new treatment option to patients who need it most: those with metastatic disease. Under Powell’s leadership, and unique to the industry, the company has strategic relationships with leading pharmaceutical companies, prompting several to invest substantially in RefleXion, and others to enter collaboration agreements to further develop its flagship technology. He has successfully led commercialization of RefleXion’s first product, which has delivered over 2,500 patient treatments, completion of its first clinical study, and initiation of a clinical registry based on real-world evidence. Furthermore, he has raised over $375 million to grow the company from 60 to 300 employees.

Powell has dedicated his career to advancing innovative cancer treatment options, which began at age 23 at industry leader Varian. Before RefleXion, he spent 12 years at Elekta, a world leader in radiation oncology, where most recently, he was Executive Vice President of Comprehensive Oncology Solutions. Previously, he spent 13 years with IMPAC Medical Systems, the original pioneer turned world leader in oncology workflow management and informatics. He advanced from Software Engineer to President and CEO at IMPAC, and helped to negotiate sale of the groundbreaking startup to Elekta. He serves as Senior Advisor for Inspovation Ventures, providing funding and advice to a selective portfolio of startups. He completed the Executive Innovation and Leadership Program at Stanford University Graduate School of Business and a Bachelor of Science in Physics and Applied Mathematics from California State University, Chico.


20. Malinka Walaliyadde
Company: AKASA
Title: Co-founder and Chief Executive Officer

Malinka Walaliyadde is a Co-founder and Chief Executive Officer of AKASA (formerly Alpha Health), which is on a mission to remedy the financial complexity crippling U.S. healthcare. The company pioneered a new approach called Unified Automation. It provides hospitals and healthcare systems with a single solution that uses the same AI and machine learning technology employed by driverless cars to improve the efficiency, accuracy, and scalability of healthcare operations, starting with revenue cycle management (RCM). AKASA brings together the best of people, data, and machine learning technology and ultimately helps health systems be better stewards of the healthcare dollar.

Prior to starting AKASA, Walaliyadde was a partner at Andreessen Horowitz (a16z), a venture capital firm in Silicon Valley with $16.5 billion in assets under management. He helped start their healthcare investment team, and worked on almost $250 million of investments across about 20 healthcare companies, ranging from new providers, payers, biotech companies, and health technology companies. Before a16z, he was an Analyst for Deloitte and worked in Product Analytics for Counsyl. He has also been a Board Attendee for PatientPing, Apeel Sciences, and Omada Health. Walaliyadde earned a Bachelor of Science in Materials Engineering with a minor in Biomedical Engineering from Cornell University.


21. Philip Settimi
Company: PartsSource
Title: President and Chief Executive Officer

Philip Settimi, MSE, MD, serves as President and Chief Executive Officer for Ohio-based PartsSource, whose pioneering evidence-based supply chain software platform and vertical marketplace serving mission-critical healthcare operations has been adopted at more than 3,500 hospitals and 15,000 clinical sites worldwide. Under Dr. Settimi’s leadership since 2014, PartsSource has developed the industry’s first Clinical Resource Management platform that uses patented algorithms and 3 billion data elements to maximize the safety, reliability, productivity, and cost-effectiveness of the medical device supply chain. During this time, PartsSource has earned ISO 9001 and 13485 certification, and extended improvement insights on product quality, logistics, and customer experience to thousands of suppliers and OEMs in the healthcare ecosystem. PartsSource’s growth and financial results are similarly impressive, and the firm was acquired to great acclaim by Bain Capital in 2021.

Dr. Settimi has also served as a member or advisor to numerous boards of healthcare technology entities, and as an operating executive to multiple leading private equity firms. He has held diverse leadership positions in public medical device and HCIT companies including Hillrom, Hospira, and GE Healthcare, and he holds numerous patents related to EMR-usage to enroll and conduct clinical studies in medicine. He received his Bachelor of Arts in Economics as well as a Master’s in Biomedical Engineering and a Doctor of Medicine, all from the University of Michigan.


22. Priya Abani
Company: AliveCor
Title: President and Chief Executive Officer

Priya Abani is the President and Chief Executive Officer at AliveCor, a healthtech company that is delivering intelligent, highly-personalized heart data to clinicians and patients anytime, anywhere. At AliveCor, Abani oversees the continued convergence of AI and healthcare to create a trusted, worldwide network for both physicians and patients through the company’s personal ECG devices, telehealth services, and technology platform. She has led the company through a period of tremendous growth, putting personal ECG technology in the hands of more than 2 million people around the world. She is responsible for launching a series of new consumer and enterprise services that advance AliveCor’s mission to save lives and transform cardiology by advancing patient-centric remote cardiological care using deep machine learning and AI.

Abani has more than 20 years of experience building high-performing organizations, launching innovative products, and leading strategic alliances across industries. Prior to joining AliveCor, she served as the General Manager at Alexa Voice Service at Amazon, where she was responsible for leading product, engineering, technical enablement, and developer experience teams, and she led the expansion of Alexa technology into partner products. She earned a Master’s in Computer Science from Clarkson University as well as a Master of Business Administration from Babson College.


23. Naomi Allen
Company: Brightline
Title: Co-founder and Chief Executive Officer

Naomi Allen is the Co-founder and Chief Executive Officer of Brightline, a leading virtual behavioral health solution built specifically to bring care to kids, teens, and parents across the country, right when and where they need it. Today, Brightline delivers integrated care through innovative technology, evidence-based programs, and a multidisciplinary care team focused on supporting families at a time when pediatric mental health rates are at an all-time high. Recognized as the pioneer in family virtual behavioral health, Brightline was listed as one of Fast Company’s 2022 Most Innovative Companies and Fierce Healthcare’s 2022 Fierce 15.

In addition to her executive role at Brightline, Allen serves on the board of Bright Health, a consumer-focused and technology-enabled health insurance company. Prior to founding
Brightline, she was the Chief Growth Officer for Livongo as well as a founding team member of
Castlight Health. Previously, she was a leader in McKinsey’s Silicon Valley office, helping to
build their West Coast healthcare practice, and she began her career as a Consultant for Deloitte. She received her Bachelor of Arts in International Studies from the University of North Carolina, Chapel Hill, and her Master of Business Administration from the Stanford University Graduate School of Business.


24. Isaac Ullatil
Company: Hallmark Health Care Solutions
Title: Co-founder and Chief Executive Officer

As Chief Executive Officer of Hallmark Health Care Solutions (HHCS), Isaac Ullatil leads the company’s mission to provide innovative health technology that solves the evolving challenges of healthcare workforce and compensation management. Under his leadership, the company has soared to No. 318 on the Inc. 5000 List of Fastest Growing U.S. Private Companies, and its solutions are saving clients millions of dollars in labor and operational costs annually. His commitment to the highest security and performance standards is evidenced by the firm’s SOC1 and SOC2 certifications and status as a Microsoft Gold Partner.

An expert in business administration and management with a strong background in private equity and a Lean Six Sigma Black Belt, Ullatil has transformed ideas into multimillion-dollar companies. Prior to HHCS, he founded other highly successful healthcare and IT businesses and held leadership roles at ECG Management Consultants, KG Global Healthcare Services, and Team Healthcare. A member of the Forbes Business Council and McKinsey’s Global Health Tech Network, Ullatil has a Master of Business Administration from Newport University, a Master’s certificate in Business Management from the A.B. Freeman School of Business at Tulane University, and a Bachelor’s in Production Engineering from the University of Pune in India.


25. Frank Watanabe
Company: Arcutis Biotherapeutics
Title: President and Chief Executive Officer

Frank Watanabe has served as the President of Arcutis Biotherapeutics since its inception in 2016, and as Chief Executive Officer since 2017. Arcutis is a biopharmaceutical company that focuses on meaningful advances in the treatment of immune mediated skin disease. With a lack of topical innovation spanning over the last 20 years, it is Arcutis’ belief that patients deserve better, and the company strives to simplify disease management and optimize drug efficacy, safety, and tolerability. Under Watanabe’s leadership, Arcutis conducted a successful IPO, raised additional financing, and progressed a robust dermatology pipeline with multiple clinical programs, including one product under FDA review for plaque psoriasis and multiple phase 3 clinical programs in atopic and seborrheic dermatitis.

Watanabe was a commissioned officer in the U.S. Navy Reserves for 25 years and has over 20 years of leadership in the biopharmaceutical industry. With his leadership, Arcutis’ employee base has grown from 50 to 150 in 2021, while maintaining an annual voluntary employee turnover rate at or below 7%, far below the biotech industry average of 17%. Additionally, 97% of Arcutis employees say it is a great place to work, compared to 59% of employees at a typical U.S.-based company. Watanabe received his Bachelor of Arts in International Relations and Master of Arts in National Security Studies, both from Georgetown University.


26. Kate Quirke
Company: Alcidion
Title: Managing Director and Chief Executive Officer

Kate Quirke serves as the Managing Director and Chief Executive Officer of Alcidion, a leading provider of software solutions for high performance healthcare that empower clinicians with decision support tools to ensure the highest quality of care for their patients. Its Miya Precision platform is a next generation healthcare analytics platform powered by Fast Healthcare Interoperability Resources (FHIR) that addresses clinical workflow with AI, clinical decision support (CDS), and real time alerts to reduce clinical risk, prevent poor patient outcomes, and improve revenue.

Quirke is responsible for leading the many and varied elements of Alcidion’s business, with a particular focus on sales and marketing and developing business relationships with customers and partners across the world. She has more than 25 years of experience in the healthcare information sector. Prior to Alcidion, she was one of five working Directors for MKM Health. She has been involved in large systems procurements and implementations across Australia and Asia Pacific. In 1999, she was a member of the management buyout team that created iSOFT Asia Pacific through a merger with iSOFT plc in the U.K., from the healthcare product business at Computer Sciences Corporation (CSC). Prior to that, she held senior account roles at CSC (now DXC), managing large outsourcing customers and the New South Wales Healthcare Business unit.

Quirke began her private sector career at McDonnell Douglas Information Systems, managing the HOMER product portfolio, after working with the Alfred Group of Hospitals in a Health Information Management role. In March 2022, she became a Non-Executive Director of ANDHealth, Australia’s only business accelerator dedicated to digital health commercialization and investment readiness. She has a Bachelor of Applied Science in Health Information Management from La Trobe University in Melbourne, Australia.


27. Alif Saleh
Company: Scipher Medicine
Title: Chief Executive Officer

Alif Saleh is Chief Executive Officer of Scipher Medicine, a Waltham, Massachusetts-based precision immunology company on a mission to match each patient with their most effective therapy.

Saleh is a pioneer in using network science and artificial intelligence to solve some of healthcare’s most difficult challenges. Concerned by the healthcare system’s inability to prescribe the right drugs to the right patients, he and his team are developing and commercializing precision diagnostics and therapeutics for autoimmune diseases. Under his leadership, Scipher has raised $227 million to support its mission, more than $190 million of which came over two successful rounds in the last 13 months.

Before Scipher, he co-founded Starling Trust Sciences, an applied behavioral sciences company using machine learning and network science to build augmented management intelligence tools. Prior to that, he was Senior Vice President of Sales and Marketing at Myriant and later led the company’s Succinic Acid and Derivatives Strategic Business Unit. He also worked for Sweden-based Alfa Laval, where he held project management and marketing positions in the company’s global petrochemical and refinery business unit, ultimately heading up Alfa Laval’s most profitable product group in Asia.

Saleh received his Master of Science in Chemical Engineering from Lund Institute of Technology in Sweden.


28. Bret A. Larsen
Company: eVisit
Title: Co-founder and Chief Executive Officer

Well before the pandemic, Bret Larsen co-founded eVisit with the mission to simplify healthcare delivery to everyone, everywhere. Since 2015, his team has helped enterprise-level healthcare organizations and hospital systems – including some of the largest in the U.S. – leverage technology to deliver telehealth services in the rapidly evolving, highly competitive healthcare environment. Their proprietary platform connects patients to providers, powers millions of virtual visits, and eliminates administrative burdens. eVisit was recognized as the sole industry leader in the Forrester Wave™: Virtual Care Platforms in Digital Health, Q1 2021, and was a Representative Vendor in the Gartner® 2020 Market Guide for Virtual Care. The company was named for the first time as one of America’s fastest-growing companies in 2021, ranking no. 2,300 on the prestigious Inc. 5000 List.

Prior to launching eVisit, Larsen’s roles included: Vice President of Marketing at edtech SaaS firm CampusLogic, Director of Marketing Strategy at customer-experience design company TallWave, and Marketing Lead at healthtech company Stat Heath, where he successfully built the Stat Doctors brand. He currently serves on the boards of Welby Health, Tactic, and Sweater. He received Bachelor of Arts degrees in both Accounting and Marketing from the W.P. Carey School of Business at Arizona State University.


29. Brett Shaheen
Company: Redesign Health
Title: Founder and Chief Executive Officer

Brett Shaheen founded Redesign Health in 2018, guided by his belief that redesigning health for everyone can only be done at scale. Today, he serves as Redesign Health’s Chief Executive Officer, where he leads his team of 150+ employees in developing technologies, tools, and insights that enable the company to rapidly power and scale innovation in healthcare. Since 2018, Redesign Health has built more than two dozen healthcare companies – including MedArrive, Jasper, Calibrate, Anomaly, and Duos – and its ecosystem of 1000+ employees continues to innovate across pain points in healthcare. Under Shaheen’s leadership, Redesign Health has impacted over ten million people, providing cancer care, teleaudiology, and COVID-19 testing, among many other critical areas of care.

Prior to launching Redesign Health, Shaheen was a Managing Director and Lead Healthcare Analyst at Lone Pine Capital. There, he witnessed firsthand the inefficiencies of the healthcare industry and the challenges founders face when building and launching a startup. He was motivated to build a solution that lowered the barriers to change across the industry, which ultimately became Redesign Health.

He earned a Bachelor of Science and Bachelor of Arts from the Wharton School of the University of Pennsylvania. He holds a Master of Business Administration from Harvard Business School and a Master of Philosophy from Oxford University, where he was a Rhodes Scholar.


30. Tim Daugherty
Company: Millar
Title: President and Chief Executive Officer

Tim Daugherty has served as President and Chief Executive Officer of Millar since July 2016. Millar is known as a leader in the innovation of MEMS sensor-enabled devices from mouse to man, supporting medical advancements from heart failure research in mice to providing clinical pressure feedback data through integrated medical devices. Daugherty believes that Millar makes a difference in the lives of patients, clinicians, and researchers every day and that the company’s purpose is to push the limits of technology, enabling new scientific discoveries and expanding the boundaries of medical understanding. His unwavering commitment to this core purpose guides his approach to developing Millar’s long-term strategy.

Shortly after assuming his current role, he spearheaded a shift in Millar’s strategy, making the integration of Millar’s market-leading MEMS pressure sensors into a wider range of medical devices a top priority. He joined Millar in 2003 as a Technical Sales & Support Engineer, where he worked initially with the cardiovascular product lines. Over the next 13 years, he served in increasingly broader roles, including Product Manager, Director of Sales & Marketing, and President, before being named CEO in 2016. Growing up in Texas, Wyoming, and Kentucky, Tim earned a Bachelor of Science with Honors in Biomedical Engineering from Texas A&M University.


31. Lishan Aklog
Company: PAVmed Inc.
Title: Chairman and Chief Executive Officer

Dr. Lishan Aklog is Chairman and Chief Executive Officer of PAVmed Inc., a commercial stage multi-product medical technology company which he co-founded based on a portfolio of his own innovations, including in carpal tunnel syndrome and infusion therapy. He is also Executive Chairman of its major subsidiary, Lucid Diagnostics Inc., which markets the only commercially available tools for early precancer detection to prevent esophageal cancer in patients with chronic heartburn. He previously co-founded Pavilion Holdings Group, which created four medical device companies, including Vortex Medical, which developed and commercialized his life-saving invention AngioVac®.

Prior to entering the life sciences industry, Dr. Aklog had a distinguished academic and clinical career as a technological innovator in cardiac surgery, serving on the faculty of leading institutions, including Harvard Medical School and the Mount Sinai School of Medicine. He also serves on the board of directors of two life sciences companies, and the leading medical technology trade association, AdvaMed. Dr. Aklog, who fled political violence in Ethiopia as a young teenager, has been active in philanthropic organizations, including as a member of the international board of directors of Human Rights Watch. He received his Bachelor of Arts in Physics from Harvard University and his Doctor of Medicine from Harvard Medical School.


32. Kent Ivanoff
Company: VisitPay
Title: Co-founder and Chief Executive Officer

Leveraging his considerable expertise in the world of finance, Kent Ivanoff co-founded patient financial engagement platform VisitPay in 2010 and currently leads the firm as Chief Executive Officer. VisitPay was designed to revolutionize the patient payment experience, increasing both patient loyalty and financial results for healthcare providers while streamlining the payment process from end to end. Since then, VisitPay has expanded to serve millions of patients for enterprise health systems with almost $100 billion in net patient revenue.

Ivanoff has a great deal of experience in the world of finance, having worked in an executive vice presidential role at Capital One Financial for nearly a decade and co-founding credit card origination and servicing startup American Direct Credit, which Capital One later acquired. Outside his current role as CEO of VisitPay, Ivanoff has served on the boards of Cambia Health Solutions and the transformative, tuition-free high school One Stone. He received his Bachelor of Science in Chemical Engineering from the University of Idaho and his Master of Business Administration in Finance and General Management from the Stanford University Graduate School of Business.


33. Ryan A. Grant
Company: Vori Health
Title: Founder and Chief Executive Officer

Ryan A. Grant, MD, MBA is the Founder and Chief Executive Officer of Vori Health. Dr. Grant is a serial entrepreneur and board-certified, Yale-trained neurosurgeon who was most recently at Geisinger Medical Center practicing complex spine surgery. He left his surgical practice during the pandemic to focus on value-based healthcare transformation starting in the musculoskeletal sector, which includes back/hip/knee pain. Vori Health is an award-winning, nationwide, virtual-first, musculoskeletal medical practice focused on evidence-based care that treats the whole person. Using a unique care model to help patients find the best path forward, Vori Health connects patients to a trained care team that includes a nonoperative physical medicine physician, a health coach navigator, and a physical therapist who manage the initial patient assessment and then work to coordinate all aspects of care.

Prior to Vori Health, Dr. Grant co-founded Nomad Health, which is an award-winning online marketplace that directly connects healthcare clinicians to healthcare jobs, participated in medical device development, and taught at several medical schools and universities. He received his Bachelor of Science and Master of Science from the University of Michigan, his Doctor of Medicine from the University of Pennsylvania, and completed his neurosurgical residency and complex spine fellowship at Yale University.


34. Richard Uhlig
Company: Quadrant Biosciences
Title: Founder and Chief Executive Officer

Richard Uhlig is the Founder and Chief Executive Officer of Quadrant Biosciences, an award-winning life sciences lab that is based in Syracuse, New York. By leveraging the power of artificial intelligence and machine learning, Quadrant uses algorithms, based on large data sets, to discern trends. The company developed the Clarifi testing platform, which can be used to detect diseases and disorders, including traumatic brain injury, autism spectrum disorder, and even COVID-19. Recently, the company has hit many milestones, including developing the world’s first saliva based epigenetic test for autism spectrum disorder. In 2020, sales from their new saliva COVID-19 tests exceeded $6.5 million.

Uhlig spent years on Wall Street before taking on a new path as the CEO of Quadrant. Previously, he was head of liquidity risk at the Federal Reserve Bank of New York. Before that, he was the Chairman and CEO of Morgan Stanley Bank, the principal banking subsidiary of Morgan Stanley, and was the Chief Investment Officer at Merrill Lynch Bank. He held other significant posts in the financial industry and served as an executive-in-residence at Cornell University’s Johnson Graduate School of Management. He received his Bachelor’s degree from Cornell University.


35. James M. Haefner
Company: Athenix Body Sculpting Institute
Title: Founder and Chief Executive Officer

James Haefner, Founder and Chief Executive Officer of Athenix Body Sculpting Institute, is a cosmetic surgery industry veteran. He launched Athenix in 2010 with the vision of creating a trusted brand in which consumers could have confidence and that would help them achieve outstanding cosmetic results in a safe, welcoming environment. Under his leadership, Athenix has grown to be the largest aesthetic plastic surgery center on the West Coast. Over the past decade, Athenix has gained widespread recognition due to its unparalleled cosmetic results and first-in-class patient experience that attracts patients from across the U.S. and internationally.

In 2021, Athenix achieved record sales and profitability and consummated a private equity capital raise to accelerate national expansion. Haefner states, “It’s the relentless focus on our patients that has enabled our continued growth.”

Haefner, a proponent of philanthropic endeavors, created the #AthenixGivesBack program in 2019. It was established to honor and celebrate stories of persistence and resolve. The program donates cosmetic surgeries to individuals who have impacted the lives of others. By highlighting incredible women, the goal at Athenix is to empower other wellness journeys and improve patients’ quality of life.

Haefner earned his Master of Business Administration from the University of Southern California and a Bachelor of Business Administration from Eastern Michigan University.


36. Fabian Gerlinghaus
Company: Cellares
Title: Co-founder and Chief Executive Officer

Fabian Gerlinghaus is Co-founder and Chief Executive Officer of Cellares, a San Francisco, California-based biotechnology company working on cell therapy solutions. In 2019 Fabian helped start the company, which has raised more than $100 million in less than two years. Cellares is developing a scalable, end-to-end automated solution for industrial cell therapy manufacturing. The company’s “factory-in-a-box” utilizes robust and reproducible cell processes that can deliver real cost savings, improved efficiency, and true scalability.

Prior to Cellares, Fabian served as Chief Innovation Officer at Synthego, where he co-invented the company’s proprietary RNA synthesizer technology. He spearheaded the development efforts to take a whiteboard sketch of the device and turn it into a production-ready instrument within two years, enabling the company to be the first to market with its CRISPR/Cas9 product portfolio. Fabian received his Master’s in Aerospace Engineering from the Technical University of Munich, and an Honors Degree in Technology Management from the Center for Digital Technology and Management in Munich.


37. Omid Farokhzad
Company: Seer Inc.
Title: Founder, Chief Executive Officer, and Chair

Omid Farokhzad is the Founder, Chief Executive Officer, and Chair of Seer Inc. (Nasdaq: SEER), a proteomics platform company based in the San Francisco Bay Area. Seer’s nanoparticle technology enables deep and unbiased interrogation of the proteome in complex samples such as plasma, in a rapid and scalable workflow. The nanoparticles are engineered with tunable, unique physiochemical properties to enable reproducible and selective binding with nearly infinite combinations of distinct nanoparticle designs.

Omid previously co-founded Selecta Biosciences Inc. (Nasdaq: SELB), which is developing a novel antigen-specific tolerance platform for biologics and gene therapy; Tarveda Therapeutics Inc., a privately-held oncology biotherapeutics company; and BIND Therapeutics, a nanoengineering company acquired by Pfizer. In 2015, he was named one of The Worldview 100 by Scientific American, which recognizes visionaries who shape biotechnology around the world; and in 2016, he was among the recipients of the Ellis Island Medal of Honor for his scientific, societal and economic contributions to America as an immigrant. Omid received his Doctor of Medicine from Boston University School of Medicine, his Master of Business Administration from the MIT Sloan School of Management, and completed his post-doctoral research training with Professor Robert Langer at the Massachusetts Institute of Technology.


38. Steve Yaskin
Company: Health Gorilla
Title: Co-founder and Chief Executive Officer

Steve Yaskin is the Co-founder and Chief Executive Officer of Health Gorilla, a national Health Information Network and interoperability provider on a mission to aggregate health records for all 330 million U.S. residents. Under Steve’s direction, Health Gorilla has secured three strategic rounds of funding totaling $80 million and developed an industry-leading FHIR-based Health Interoperability Platform. The platform consolidates complicated integrations into simple-to-implement APIs, powers fundamental healthcare workflows, and functions as an on-ramp for organizations to access and exchange data nationally.

Yaskin has over 20 years of experience investing in, founding, and developing successful technology startups. Before founding Health Gorilla, he was the Chief Technology Officer for Elite Medical Center, a provider organization specializing in Primary Care and Geriatrics. Elite Medical Center served over 50,000 active primary care and chronic disease management patients and was acquired by Carbon Health in 2020. Earlier in his career, Yaskin founded and acted as the Chief Technology Officer for Queplix. The data virtualization software firm, which was eventually acquired, enabled customers to securely integrate, deploy, and manage cloud and on-premises applications and data. At the time of acquisition, Queplix had licensed its data management software to 15 Fortune 50 companies. Yaskin earned a Bachelor of Arts in Theoretical Physics and Computer Information Systems from Brooklyn College and a Master of Science in Applied Physics from Drexel University.


39. Randy Boldyga
Company: RXNT
Title: Founder, President, and Chief Executive Officer

Randy Boldyga is the Founder, President, and Chief Executive Officer of RXNT, a cloud-based healthcare software company based in Maryland. Boldyga founded RXNT in 1999 with a vision to create a better, safer way to prescribe medications. Along with a small team, he started the e-prescribing company, and it has been privately-owned and operated ever since, with no venture capital. Today, RXNT provides the ambulatory care market with a fully-integrated suite of proven solutions that includes electronic medical records, medical billing, practice management, patient scheduling, and e-prescribing. Under Boldyga’s guidance, RXNT has become a leader in the Health IT market, with thousands of providers of all sizes and specialties trusting the system to keep their practice running smoothly.

Before founding RXNT, Boldyga led IT operations at The Columbia Bank in Maryland. Prior to that, he managed the Clinical Health Information Systems Department at the University of Arkansas Medical Sciences (UAMS), where he learned first-hand the technology challenges faced by medical teams at the point-of-care. He has also worked as an Information Technology Consultant for the Department of Defense, the Department of Energy, and the Federal Bureau of Investigation. He received a Bachelor of Science in Mathematics from the University of Maryland, Baltimore County.


40. David Medvedeff
Company: Aspen RxHealth
Title: Chief Executive Officer

David Medvedeff is a Co-founder and Chief Executive Officer of Aspen RxHealth, a company disrupting the pharmacy profession by crowdsourcing passionate pharmacists around the nation to deliver clinical patient care on behalf of payers and providers. As the leader in next-generation clinical pharmacy services, Aspen RxHealth intelligently matches pharmacists with patients based on often overlooked social and clinical factors to enrich the patient-pharmacist experience and drive better outcomes for health plans and other risk-bearing providers. Since launching Aspen RxHealth in 2018, Medvedeff and his team have built the largest community of more than 5,000 pharmacists across the nation, empowering patients with the information and action plans they need to achieve optimal health outcomes.

Prior to starting Aspen RxHealth, he served as President and CEO of several successful healthcare companies, including Gold Standard (acquired by Reed Elsevier), Avatar International (acquired by Press Ganey Associates), and VUCA Health, where he is an Executive Chairperson. His professional accomplishments have been recognized with numerous accolades, including the National Prescott Award, the Next Generation Pharmacist Technology Innovator, and he is the only two-time winner of the American Pharmacists Association Foundation’s Pinnacle Award. Medvedeff studied organic chemistry at the University of Florida, where he earned his Doctor of Pharmacy and Master of Business Administration. He has served on the faculty of the College of Pharmacy as an Associate Professor and has received the Outstanding Alumnus and the Outstanding Service Awards from the College.


41. Tamer Mohamed
Company: Aspect Biosystems
Title: Co-founder and Chief Executive Officer

A bioengineer, inventor, and entrepreneur, Mohamed co-founded and currently serves as President and Chief Executive Officer of Aspect Biosystems, a biotechnology company developing bioprinted tissue therapeutics to transform how we treat disease. The company is leveraging its proprietary bioprinting technology, therapeutic cells, and materials science to create a pipeline of cell-based tissue therapeutics that replace or repair damaged organ functions.

As a leader and visionary in the field of regenerative medicine, Mohamed has been invited to speak at venues ranging from TEDx to scientific and executive conferences. He was awarded with British Columbia’s Top 40 Under 40 award for demonstrating excellence in business, leadership, and community contribution. He serves on the Board of Directors for The Stem Cell Network, an organization focused on building Canada’s stem cell and regenerative medicine research sector, and is an Advisory Board Member for The Knowledge Society (TKS), an organization focused on training young people to solve the world’s biggest problems using emerging technologies. He is also on the Investment Committee for the Praxis Spinal Cord Institute, a global initiative focused on accelerating progress towards a world without paralysis after spinal cord injury. He received his Bachelor of Applied Science and Master of Applied Science in Electrical and Computer Engineering from the University of British Columbia.


42. Jim Flatt (tie)
Company: Brightseed
Title: Co-founder and Chief Executive Officer

Jim Flatt is a Co-founder and Chief Executive Officer of Brightseed, a fast-growing biotechnology company that is using AI to fortify our food with miracle ingredients found in plants. Not unlike the way Google indexed the Internet, Brightseed is in the early stages of indexing the plant kingdom’s molecular structures in order to uncover previously unknown compounds that offer health benefits to men and women. The company was founded in 2017 and is headquartered in San Francisco, California. In June 2020, the World Economic Forum named Brightseed one of its 2020 Technology Pioneers, a distinction it bestows on companies shaping the future via their emerging technologies.

Flatt, no stranger to the biosciences sector, has a 35-year track record of transforming scientific breakthroughs and advances in technology into popular health products. Prior to founding Brightseed, he was Chief Technology Officer for Synthetic Genomics, a leader in synthetic biology. He also led R&D at Martek Biosciences and Mascoma. He received his Bachelor of Science in Chemical Engineering from the Massachusetts Institute of Technology, his Master of Science in Chemical Engineering from the University of California, Berkeley, and a Doctor of Philosophy in Chemical and Biochemical Engineering from the University of Wisconsin-Madison.


42. Scott Durbin (tie)
Company: Viveve Medical, Inc.
Title: Director and Chief Executive Officer

Scott Durbin is the Director and Chief Executive Officer of Viveve, a medical technology company focused on women’s intimate health. He joined Viveve in early 2013 as Chief Financial Officer and was promoted to CEO in mid-2018. He has been instrumental in leading Viveve through periods of rapid growth and global expansion, including development and execution of many innovative “first ever” strategies in clinical development, marketing, and commercialization of the company’s revolutionary Viveve® System. A novel dual-energy technology platform device, Viveve System is currently available in the U.S. under a general surgery FDA clearance and has received regulatory approvals and clearances in 50 countries for the treatment of vaginal laxity or improvement in sexual function indications. In the U.S., Viveve is currently conducting an FDA approved pivotal clinical trial for stress urinary incontinence (SUI). Topline results from this fully enrolled trial are anticipated at the end of 2022. If positive, results may support a new U.S. indication and address an unmet medical need for a non-invasive single-session treatment option for the estimated 25-30 million women in the U.S. who suffer daily from SUI.

Durbin’s 25 years of leadership experience in the life sciences industry cover corporate finance, strategic development, clinical science, operations, and commercial business. Prior to joining Viveve, he was Chief Financial Officer of Aastrom Biosciences, a publicly traded, cardiovascular cell therapy company. Before Aastrom, he spent six years as Chief Operating and Financial Officer for Prescient Medical, Inc. He began his career in corporate finance as an Investment Banker in the healthcare and M&A groups at Lehman Brothers Inc., where he focused on mergers and acquisitions and financings for the life sciences industry. He received his Bachelor of Science in Biopsychology/Pre-Med from the University of Michigan and a Master of Public Health in Health Management from Yale University.


43. Ben Bergo
Company: Visus Therapeutics
Title: Co-founder and Chief Executive Officer

Ben Bergo is Co-founder and Chief Executive Officer at Visus Therapeutics, a clinical-stage pharmaceutical company focused on developing innovative ophthalmic therapies to improve vision for people around the world. Ben is currently spearheading the development of Visus’ lead product, BRIMOCHOLTM PF, a prescription eye drop being studied to correct the loss of near vision associated with presbyopia. Driven by the company’s mission of offering patients a lifetime of clear vision, Bergo recognizes the importance of a diverse portfolio. He is leading Visus in advancing its pipeline of early-stage ophthalmic drug candidates with applications in corneal wound healing, glaucoma, and age-related macular degeneration.

Bergo has more than 20 years of experience in life sciences. Prior to Visus, he served as Executive Vice President of Corporate Development at Planet Innovation, where he led licensing and M&A transactions on behalf of the Planet Group. Additionally, he served as Co-founder and CEO at Nohla Therapeutics, Inc., a leader in the development of off-the-shelf cell therapies utilizing proprietary expanded cord blood formulations. Prior to this, he spun out technologies from Harvard University into a diagnostics venture that was later sold in 2015. He received a Master’s in Applied Finance from Macquarie University as well as a Bachelor of Engineering and a Bachelor of Commerce in Economics and Finance, both from the University of Melbourne.


44. Timothy Moran
Company: Motus GI Holdings
Title: Chief Executive Officer

Timothy Moran is the Chief Executive Officer of Motus GI Holdings, a medical technology company that specializes in endoscopy solutions associated with the diagnosis and management of gastrointestinal conditions. The company’s flagship product is the Pure-Vu® System, a U.S. FDA-cleared medical device that helps facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. Motus reported a steady increase in commercial momentum during the second half of 2020 compared to the first half of the year — despite the limited access to hospitals for many people because of the ongoing pandemic.

Ever since joining Motus in 2018, Moran has leveraged his broad commercial experience and leadership in the medical technology sector to drive growth for the company. He’s been responsible for leading the development of the company’s short and long-term strategies, providing daily oversight, and communicating on behalf of Motus to shareholders and government agencies alike. Before Motus, he held roles in management and sales for over two decades at ConvaTec and Covidien. Moran also served on the CEO Advisory Council for Advanced Medical Technology Association (AdvaMed), a medical device trade association. Moran received his Bachelor of Arts in Organizational Communication at The State University of New York at Geneseo.


45. Brian Pepin
Company: Rune Labs
Title: Chief Executive Officer

Brian Pepin is a healthtech entrepreneur with a focus on neurological and neuropsychiatric disorders. He is a Co-founder and the Chief Executive Officer of Rune Labs, a brain data company empowering the development and delivery of precision neuroscience therapeutics. The company aims to bring the power of data generated by the brain to help inform the development of new therapeutics for diseases such as Parkinson’s and other neurological disorders, while also providing a platform for clinicians to tailor care by having a longitudinal view of their patients’ diseases and symptoms. In September 2021, it secured $22.8 million in a Series A funding round.

While he trained as a circuit designer at university, Pepin has morphed over the last decade into mostly working on software and data products. Prior to co-founding Rune in 2018, he spent nearly five years at Verily Life Sciences – which was launched from Google X in 2015 – as a Hardware Engineer and then a Senior Hardware Engineer. At Verily, he was the engineering lead for Galvani – a collaboration with GlaxoSmithKline to develop implantable devices to deliver peripheral nerve stimulation based therapies for chronic disease. He received a Master of Science in Electrical Engineering from the University of California, Berkeley and a Bachelor of Science in Electrical Engineering from the University of Washington.


46. Eliane Schutte
Company: Xeltis
Title: Chief Executive Officer

Eliane Schutte has been the Chief Executive Officer of Xeltis since 2018. Under her leadership, the company expanded its strategy to cover valve and vascular applications. She initially joined Xeltis in 2015 as Chief Development Officer, leading its clinical trial program, product development strategy, and regulatory functions. Xeltis is a clinical-stage medical device company with the world’s first polymer-based technology platform designed to enable natural restoration of heart valves and blood vessels in the body. The technology uses a patient’s own natural healing system to develop a new living functional vascular graft or heart valve. The novel technology is comprised of supramolecular polymers (a Nobel-prize awarded discovery) and uses electrospinning manufacturing methods to create a unique architecture of small diameter vascular grafts and heart valve implants.

Schutte has extensive expertise in global product development and regulatory affairs in medical devices, with over 20 years of experience in the biotech industry. Prior to Xeltis, she was Vice President for Global Product Development in Peri-operative Care at The Medicines Company. She was previously Chief Development Officer at ProFibrix, a Dutch-U.S. biotech startup acquired by The Medicines Company, and Vice President for Regulatory Affairs and EU operations at IsoTis Orthobiologics.


47. Timur Ozekcin
Company: Cylera
Title: Co-founder and Chief Executive Officer

Timur Ozekcin is the Co-founder and Chief Executive Officer of Cylera, a leader in agentless cybersecurity and intelligence, with a mission to safeguard the devices that matter most to leading organizations across healthcare providers, enterprises, and government agencies. The company delivers a holistic, asset-centric cybersecurity platform that identifies all devices, analyzes risks and vulnerabilities, and mitigates threats in real-time, helping organizations separate the signal from the noise.

Having experience in healthcare cybersecurity policy and biomedical engineering, Ozekcin leads Cylera through the ever-changing healthcare industry to deliver world class technologies to its global healthcare clients. Prior to Cylera, he was the Co-founder of a medical device and technology startup Heuristics Health. Additionally, he worked for a non-profit consortium funded by the Department of Homeland Security focused on the safety and security of medical devices within healthcare organizations. He holds a Bachelor of Science in Biological Engineering, a Master’s in Mechanical Engineering from Cornell University, and a Master’s in Public Health focusing on Healthcare Policy from Columbia University.


48. Amy Shecter
Company: Ever/Body
Title: Chief Executive Officer

Amy Shecter joined Ever/Body in late 2020 and has accelerated the company’s path to become the leading provider of cosmetic dermatology for the 21st century. Ever/Body is transforming the industry with personalized body, skin, and hair treatments and a modern approach to a digital and physical experience. Under her leadership, it grew by 257% YOY, and launched a first-of-its-kind enhanced education program to support the brand’s mission of supporting each client on their personal beauty journey. The company closed its Series B funding round of $38 million in the spring of 2021, and the company has plans underway to open seven new locations across two markets by the end of 2022.

Prior to joining Ever/Body, Shecter was the CEO of GLAMSQUAD, a technology-powered, consumer-focused company that provides on-demand, at-home beauty services. At GLAMSQUAD, she rapidly scaled the business, opened new markets, launched proprietary technology, forged strategic partnerships, and launched branded products. She received a Bachelor of Science in Fashion Marketing from the University of Massachusetts and actively provides mentorship to prospective business leaders and entrepreneurs within her network.


49. Henry O’Connell
Company: Canary Speech
Title: Chief Executive Officer

Henry O’Connell is the Chief Executive Officer of Canary Speech, a Provo, Utah-based company that has developed technology to detect diseases and other conditions through human speech. The company’s product uses machine learning to diagnose and track conditions such as Alzheimer’s disease, Parkinson’s, PTSD, and depression.

O’Connell has over 20 years of executive and C-level experience. Following graduate school, he began his career at the National Institutes of Health in a neurological disease group and continued on to a successful business career specializing in turnaround situations in the tech industry. He specifically enjoys transition management with rapid change and demanding challenges.

Prior to Canary Speech, he was the President and CEO of MOXTEK, a leading supplier of advanced nano-optical and x-ray components used in display electronics, imaging, and analytical instrumentation. Before that, he was the President of both Dynex Technology and IDEX Corporation. He received a Master of Science in Biochemistry from the University of Connecticut School of Medicine and a Bachelor of Arts in Biology and Psychology from Wabash College.


50. Garth Sutherland
Company: The Insides Company
Title: Chief Executive Officer

Garth Sutherland is Chief Executive Officer of The Insides Company, a leading provider of medical devices for patients with severe intestinal failure. The company’s flagship product, The Insides System, enables patients to recommence oral nutrition and return home from hospital earlier. It does this by enabling a patient-managed feeding process called chyme reinfusion. In 2021, The Insides System won Gold in the Gastrointestinal and Genitourinary Devices category at the Medical Design Excellence Awards. It is now in use at many of the world’s leading specialist hospitals that treat patients with severe intestinal failure.

In addition to The Insides Company, Sutherland is Advisor to the Healthtech Activator service, a government initiative to help build capability within the healthtech sector. He also provides advice directly to early-stage healthcare companies on a Give First basis.

Prior to The Insides Company, he founded and grew digital therapeutics company Adherium through to an IPO. In 2019, Fast Company named Adherium number 6 on its list of the 50 most innovative health companies in the world. Electronic clinical data generated by Adherium contributed to international changes to the management guidelines for mild persistent asthma.

Sutherland received his Master of Science in Physics from the University of Waikato and has completed further education at the MIT Sloan School of Management and the UCLA Anderson School of Management.

The Top 50 Healthcare Technology CEOs of 2022

Next Post

Nissan eyes third plant, possibly for EVs

YOKOHAMA, Japan — Nissan Motor Co., fresh off unveiling plans to add electric vehicle production at a second U.S. assembly plant, is now contemplating building a third “factory,” possibly for EVs, in the region by 2030. Chief Operating Officer  Ashwani Gupta said the Japanese automaker would likely need a new […]
Nissan eyes third plant, possibly for EVs

You May Like

Subscribe US Now